Categories Earnings Calls, Health Care

Johnson & Johnson (JNJ) Q2 2021 Earnings Call

Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021

Corporate Participants:

Christopher DelOrefice — Vice President, Investor Relations

Joseph J. Wolk — Executive Vice President, Chief Financial Officer

Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals

Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health

Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices

Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer


Louise Chen — Cantor Fitzgerald Securities — Analyst

Larry Biegelsen — Wells Fargo Securities LLC — Analyst

Chris Schott — J.P. Morgan Securities LLC — Analyst

Bob Hopkins — BofA Securities, Inc. — Analyst

Joshua Jennings — Cowen and Company — Analyst

Terence Flynn — Goldman Sachs & Co. LLC — Analyst

Matt Miksic — Credit Suisse Securities (USA) LLC — Analyst

Joanne Wuensch — Citi — Analyst

Jayson Bedford — Raymond James Financial Inc. — Analyst


To read the full earnings call transcript, click here

Most Popular

Salesforce stock hit by weak guidance, co-CEO’s exit. What next?

For technology stocks, 2022 has been a challenging year, with companies losing significant market value amid prolonged stock selloff. In that respect, Salesforce, Inc. (NYSE: CRM) is among the worst-affected

Macy’s (M): Here’s a look at the retailer’s expectations for the near term

Shares of Macy’s Inc. (NYSE: M) were down on Thursday. The stock has gained 36% over the past three months and 18% over the past one month. The company’s sales

KR Earnings: Kroger Q3 sales, profit increase and top expectations

Department store chain The Kroger Co. (NYSE: KR) on Thursday said its third-quarter sales and adjusted earnings increased year-over-year. The latest numbers also exceeded the market's expectations. Net earnings attributable to

Add Comment
Viewing Highlight